Uploaded on Nov 4, 2022
The report "Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability (Reusable), & End Users (Hospital, ACSs/Clinic)- Global Forecast to 2027", is projected to reach USD 3.7 billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 7.9% during the forecasted period (2022 to 2027).
Bronchoscopy Market
Bronchoscopy Market
Global Forecast to 2027
Bronchoscopy Market is
expected to reach
USD 3.7 billion by 2027
Growing at a
CAGR of 7.9% (2022 – 2027)
BRONCHOSCOPY MARKET
MARKET
CAGR of OPPORTUNITY OVER KEY MARKET PLAYERS BY PRODUCT
2022 – 2027 NEXT 5 YEA3.R7 SBn
CAGR Olympus Corporation (Japan)2.5 Bn FlexibleKARL STORZ (Germany)
Ambu A/S (Denmark) Rigid
Boston Scientific Corporation (US) EBUS
Ethicon (US)
2022 2027
FUJIFILM Holdings Corporation (Japan)
Medtronic (Ireland)
BY REGION BY APPLICATION
• North America Bronchial
• Europe Treatment
• Asia Pacific Bronchial Diagnosis
• Rest of the World
The report "Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems
(Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability
(Reusable), & End Users (Hospital, ACSs/Clinic)- Global Forecast to 2027", is projected to reach USD 3.7
billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 7.9% during the forecasted period (2022 to
2027).
Browse in-depth TOC on " Bronchoscopy Market"
301- Tables
48- Figures
289- Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40057877
The growth in this market growth is largely driven by the rising prevalence of respiratory diseases, the growing
demand for minimally invasive surgeries, growing hospital investments in bronchoscopy facilities, and technological
advancements in bronchoscopes. On the other hand, the dearth of trained physicians and pulmonologists is a
major challenge to the growth of this market.
“The adult patients are accounted to hold the largest share of the bronchoscopy industry, by patients
in 2021.”
On the basis of patients, the bronchoscopy equipment market is segmented into adult patients and pediatric
patients. The adult patients segment accounted for the larger share of the bronchoscopy equipment market in
2021. The large share of this segment can be attributed to the high image quality achieved through reusable
bronchoscopes and the availability of reusable accessories.
“The hospitals are accounted to hold the largest share of the bronchoscopy market, by end users in
2021.”
Based on end users, the bronchoscopy equipment market is segmented into hospitals and ambulatory surgery
centers/clinics. The hospitals segment accounted for the largest share of the bronchoscopy equipment market in
2021. The large share of this segment can be attributed to the high patient preference for hospital treatment,
availability of skilled healthcare professionals, and favorable reimbursement scenario.
“North America accounted the largest share of the bronchoscopy market in 2021.”
The large share of the North American market can be attributed to the increasing incidence and prevalence of
chronic respiratory diseases, favorable reimbursement scenario in the US, the rising incidence of lung cancer in
Canada, rapid increase in healthcare expenditure, easy accessibility to advanced technologies, and the strong
presence of market players in the region
The major players operating in this market are Olympus Corporation (Japan), KARL STORZ (Germany), Ambu A/S
(Denmark), Boston Scientific Corporation (US), Ethicon (US), FUJIFILM Holdings Corporation (Japan), Medtronic
(Ireland), HOYA Corporation (Japan), Richard Wolf GmbH (Germany), Cook Medical (US), Broncus Medical Inc.
(China), CONMED (US), Roper Technologies (US), Teleflex Incorporated (US), Laborie Medical Technologies Corp.
(Canada), EFER Endoscopy (France), EMOS Technology GmbH (Germany), VBM Medizintechnik GmbH (Germany),
Hunan Vathin Medical Instrument Co., Ltd. (China), and Machida Endoscope Co., Ltd. (China)
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=40057877
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which
will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries
worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the
"Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new
opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500
MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players)
annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000
companies this year for their revenue planning and help them take their innovations/disruptions early to the
market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects
over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market
sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
View Full Report - https://www.marketsandmarkets.com/Market-
Reports/bronchoscopes-market-40057877.html
Comments